Tuis000538 • SHE
add
Yunnan Baiyao Group Co Ltd
Vorige sluiting
¥56,15
Dagwisseling
¥55,91 - ¥57,50
Jaarwisseling
¥44,88 - ¥67,10
Markkapitalisasie
101,02 mjd CNY
Gemiddelde volume
8,64 m
P/V-verhouding
23,83
Dividend-opbrengs
3,02%
Primêre beurs
SHE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 9,46 mjd | 0,86% |
Bedryfskoste | 1,34 mjd | -3,20% |
Netto inkomste | 1,14 mjd | -12,16% |
Netto winsgrens | 12,03 | -12,89% |
Wins per aandeel | 0,63 | 3,28% |
EBITDA | 1,22 mjd | 0,81% |
Effektiewe belastingkoers | 15,02% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 15,56 mjd | 16,33% |
Totale bates | 55,61 mjd | 4,28% |
Totale aanspreeklikheid | 15,07 mjd | 12,08% |
Totale ekwiteit | 40,54 mjd | — |
Uitstaande aandele | 1,78 mjd | — |
Prys om te bespreek | 2,47 | — |
Opbrengs op bates | 5,29% | — |
Opbrengs op kapitaal | 7,00% | — |
Kontantvloei
Netto kontantverandering
(CNY) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,14 mjd | -12,16% |
Kontant van bedrywe | 811,52 m | 140,35% |
Kontant van beleggings | -952,21 m | -519,49% |
Kontant van finansiering | -516,18 m | -2 102,36% |
Netto kontantverandering | -659,43 m | -221,90% |
Beskikbare kontantvloei | -287,03 m | 85,96% |
Meer oor
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024 state, individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
Gestig
1902
Webwerf
Werknemers
8 834